Sands Active Medicare 2026 exhibition drew significant attention as Sands Active Ltd. showcased its expanding pharmaceutical portfolio at one of Sri Lanka’s largest healthcare events.
Sands Active Medicare 2026 exhibition showcases pharma range
Sands Active Ltd., a subsidiary of the Melwa conglomerate, participated in the 15th edition of the Medicare International Healthcare Exhibition 2026, held at the Bandaranaike Memorial International Conference Hall (BMICH) in Colombo. The company used the platform to present a wide range of pharmaceutical products to a diverse audience, including healthcare professionals, industry stakeholders, and the general public.
The exhibition, widely regarded as Sri Lanka’s premier healthcare event, brought together over 150 local and international exhibitors, highlighting the latest advancements in healthcare services, medical technology, wellness solutions, and medical tourism. Within this setting, Sands Active Medicare 2026 exhibition presence stood out, as the company focused on both product visibility and public education.
Throughout the event, company representatives conducted awareness sessions aimed at educating visitors on the benefits, correct usage, and safety considerations of their medicines. This approach aligned with broader industry efforts to promote responsible healthcare practices and improve patient knowledge in a rapidly evolving medical landscape. Visitors engaged actively with the sessions, reflecting growing consumer interest in understanding pharmaceutical products beyond basic usage.
One of the key highlights at the Sands Active Medicare 2026 exhibition stall was the strong demand observed for the company’s paracetamol product, Meldol. The product attracted considerable attention from attendees, indicating consumer trust and increasing demand for reliable, locally manufactured pharmaceutical solutions. The response also underscored the importance of affordability and accessibility in Sri Lanka’s healthcare sector, particularly for commonly used medications.
Established in 2018, Sands Active operates as part of the Melwa group, a conglomerate primarily known for its leadership in steel manufacturing. In recent years, the company has expanded into the pharmaceutical sector, focusing on the production and distribution of high-quality medicines for the domestic market. Its portfolio includes oral tablets, capsules, and injectable drugs, catering to a wide range of healthcare needs.
A core objective of Sands Active is to make essential medicines more accessible and cost-effective for the Sri Lankan population. This is particularly relevant in a market where healthcare affordability remains a key concern for many households. By investing in local manufacturing capabilities, the company contributes to reducing dependency on imports while strengthening the resilience of the domestic pharmaceutical supply chain.
Quality assurance remains central to the company’s operations. Sands Active adheres to stringent local and international standards in its manufacturing processes, ensuring that products meet globally accepted benchmarks for safety and efficacy. The company follows guidelines set by the World Health Organisation (WHO) and complies with European Union Good Manufacturing Practice (EU-GMP) standards. Additionally, all products are certified by Sri Lanka’s National Medicines Regulatory Authority, reinforcing regulatory compliance and consumer confidence.
The Sands Active Medicare 2026 exhibition participation also highlighted the growing role of local pharmaceutical manufacturers in supporting Sri Lanka’s healthcare ecosystem. As demand for reliable and affordable medicines continues to rise, companies such as Sands Active are increasingly positioned as key contributors to national healthcare objectives.
Beyond product promotion, the exhibition served as a platform for collaboration and knowledge exchange among industry stakeholders. It provided opportunities for companies to engage with healthcare professionals, explore partnerships, and stay informed about emerging trends in medical technology and patient care.
As the healthcare sector in Sri Lanka continues to evolve, events like Medicare 2026 play a crucial role in bridging gaps between providers, manufacturers, and consumers. For Sands Active, the exhibition not only reinforced its market presence but also demonstrated its commitment to improving healthcare accessibility through quality pharmaceutical products.